Follow Health Care Reform Insider on Twitter
Loading...
You are here:  Home  >  Opinion  -  Page 2
Latest

Innovative App provides Real-time Tracking and Analysis of ACOs

March 14, 2015  /  Opinion

Pharmspective, a health data technology company, has introduced ACOTracker, an application that monitors and analyzes ACO formation on a real-time basis.   This iPad application provides profiles of each of the ~700 ACOs now in place including their Delivery Model, participants, sponsoring entity, and care partners. Included with an ACOTracker subscription are the following:   […]

Read More →
Latest

The mortal threat to Medicaid — and how to fix it

January 6, 2015  /  Editorials, Opinion

Jan. 1 was a red-letter day for America’s provision of healthcare to its poorest residents–and we do mean red.

Read More →
Latest

Insurers can help slow healthcare spending

December 18, 2014  /  Editorials, Opinion

Last week, the Centers for Medicare & Medicaid Services (CMS) released a statement indicating that healthcare spending growth in 2013 slowed to just 3.6 percent. 

Read More →
Latest

We must protect vital “340B” drug discounts for safety net hospitals

November 21, 2014  /  Editorials, Opinion

Millions of Americans receive help every year from a federal program they have never heard of: the 340B drug discount program, which allows public and nonprofit safety-net hospitals to better provide both affordable medications and vital services to the underserved.

Read More →
Latest

Two Reasons Why Your Company’s Health Insurance Premiums Have Gone Up (And Will Keep Going Up)

November 19, 2014  /  Editorials, Opinion

As the health care exchanges prepare continue open enrollment, the more recent news is that health care premiums are… going down. Wait, what?

Read More →
Latest

Biosimilar approval is long overdue

November 13, 2014  /  Editorials

Generic versions of brand-name chemically based drugs are well-established in the U.S. market. However, even though the Food and Drug Administration (FDA) was given the authority in 2010 to create a pathway to approve a “generic” version of a biologic drug, more properly called a “biosimilar,” the agency has not approved a single one.

Read More →
Latest

Insurers: Clean up your provider networks

November 4, 2014  /  Editorials, Opinion

Many providers approach exchange plans like Medicaid, so they’re avoiding taking too many patients reimbursed at lower rates so that they don’t go out of business.

Read More →
Latest

Is the Affordable Care Act Working?

November 1, 2014  /  Opinion

After a year fully in place, the Affordable Care Act has largely succeeded in delivering on President Obama’s main promises, an analysis by a team of reporters and data researchers shows. But it has also fallen short in some ways and given rise to a powerful conservative backlash.

Read More →
Latest

Is the Affordable Care Act Working?

October 27, 2014  /  Editorials, Opinion

After a year fully in place, the Affordable Care Act has largely succeeded in delivering on President Obama’s main promises, an analysis by a team of reporters and data researchers shows. But it has also fallen short in some ways and given rise to a powerful conservative backlash.

Read More →
Latest

How Fast Are Small-Business Health Premiums Rising?

October 14, 2014  /  Editorials

Today’s question is a basic one: Will premiums for small businesses rise in 2015, and if so, how steeply?

Read More →